INVYMAB
Live / Applied — Third extension granted (statement of use) (as of 24 Dec 2025)
What this means for you
Not registered yet, but its 25 Sept 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98196202
- Mark type
- Word mark
- Filed
- 25 Sept 2023
- Published for opposition
- 25 Jun 2024
- Attorney of record
- James J. Saul
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances derived from monoclonal antibodies for the treatment and prevention of infectious diseases; chemical, biochemical and microbial products, namely, monoclonal antibodies being pharmaceutical preparations for the treatment and prevention of infectious diseases
Owner
- Invivyd, Inc., Waltham, MA, US
- Invivyd, Inc., Waltham, MA, US
Prosecution history
- 24 Dec 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 24 Dec 2025 — SOU EXTENSION 3 GRANTED
- 23 Dec 2025 — SOU EXTENSION 3 FILED
- 23 Dec 2025 — SOU TEAS EXTENSION RECEIVED
- 09 Aug 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 08 Aug 2025 — SOU EXTENSION 2 GRANTED
- 08 Aug 2025 — SOU EXTENSION 2 FILED
- 08 Aug 2025 — SOU TEAS EXTENSION RECEIVED
- 14 Feb 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 13 Feb 2025 — SOU EXTENSION 1 GRANTED
- 13 Feb 2025 — SOU EXTENSION 1 FILED
- 13 Feb 2025 — SOU TEAS EXTENSION RECEIVED
- 20 Aug 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 25 Jun 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 25 Jun 2024 — PUBLISHED FOR OPPOSITION